Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

688136.SS Net Margin

The Net Margin of Kexing Biopharm Co Ltd (688136.SS) is 2.24%.

Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

688136.SS Net Margin - Historical Value
Date Value
2024-12-31 2.24%
2023-12-31 -15.11%
2022-12-31 -6.86%
2021-12-31 7.51%
2020-12-31 11.40%
2019-12-31 13.42%
2018-12-31 10.58%
2017-12-31 9.65%
688136.SS Net Margin - Peers Comparison
Ticker Name Value
8247.HK Biosino Bio-Technology and Science Inc -16.17%
300439.SZ MedicalSystem Biotechnology Co Ltd 14.81%
300683.SZ Wuhan Hiteck Biological Pharma Co Ltd -10.69%
688656.SS HOB Biotech Group Corp Ltd 9.15%
002880.SZ Shenzhen Weiguang Biological Products Co Ltd 21.07%
600645.SS Vcanbio Cell & Gene Engineering Corp Ltd 6.33%
300485.SZ Beijing Science Sun Pharmaceutical Co Ltd -16.53%
000518.SZ Jiangsu Sihuan Bioengineering Co Ltd -54.05%
002022.SZ Shanghai Kehua Bio-Engineering Co Ltd -36.41%
300289.SZ Beijing Leadman Biochemistry Co Ltd -20.29%
002868.SZ Lifecome Biochemistry Co Ltd -67.89%
300204.SZ Staidson (Beijing) BioPharmaceuticals Co Ltd -44.59%
300238.SZ Guanhao Biotech Co Ltd 7.26%
603739.SS Qingdao Vland Biotech Inc 4.74%
688278.SS Xiamen Amoytop Biotech Co Ltd 29.38%
688488.SS Jiangsu Aidea Pharmaceutical Group Co Ltd -33.80%
000004.SZ Shenzhen GuoHua Network Security Technology Co Ltd -133.32%
300406.SZ Beijing Strong Biotechnologies Inc 32.11%
603387.SS Getein Biotech Inc 19.20%
300381.SZ Guangdong VTR Bio-Tech Co Ltd 3.76%
688336.SS Sunshine Guojian Pharmaceutical Shanghai Co Ltd 59.03%
603716.SS Thalys Medical Technology Group Corp -11.56%
002038.SZ Beijing SL Pharmaceutical Co Ltd -11.21%
1672.HK Ascletis Pharma Inc -23455.65%
300294.SZ China Resources Boya Bio pharmaceutical Group Co Ltd 22.88%
2616.HK CStone Pharmaceuticals -22.40%
300639.SZ Guangdong Hybribio Biotech Co Ltd -80.30%
688198.SS Beijing Balance Medical Technology Co Ltd 29.16%